Notably, treatment with T2D RBC-EVs increased Arg1 protein levels in endothelial cells, thus suggesting an active transfer of exogenous Arg1 from RBCs to the endothelium. This evidence concerns the gene ARG1 and type 2 diabetes mellitus.